Why is Nath Bio-Genes falling/rising?

As of 04-Aug, Nath Bio-Genes (India) Ltd is experiencing a decline in its stock price, currently at 182.00, reflecting a change of -0.65, or -0.36%. The stock has underperformed its sector by 1.1% today and has fallen after two consecutive days of gains. In terms of returns, the stock has seen a decrease of 15.72% over the past month and a significant drop of 23.82% over the past year, while its profits have only risen by 1.6%. Despite a relatively attractive valuation with a Price to Book Value of 0.5 and a Return on Equity of 6, the stock's long-term fundamental strength is weak, evidenced by a -0.69% CAGR growth in operating profits over the last five years.
Broader market context indicates that the stock has underperformed compared to the benchmark, with the Sensex showing a modest gain of 0.16% over the past week while Nath Bio-Genes has only increased by 0.41%. Additionally, institutional investors have reduced their stake by 1.5% in the previous quarter, indicating a lack of confidence in the stock's future performance. This decline in institutional participation, combined with falling investor engagement as shown by a 12.39% drop in delivery volume, suggests that the stock is struggling to attract interest, contributing to its recent price decline.